Tu1752: SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) USE REDUCES RISK OF COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Abstract

Peer reviewed

Abdullah Sohail, Sayed Tauseef Ahmad Jan, Adnan Malik, Muhammad M. Bhinder and Douglas G. Adler

Gastroenterology (New York, N.Y. 1943), Vol.169(1 Suppl), p.S-1475

05/2025

DOI: 10.1016/S0016-5085(25)04281-7

View Online

Title: Subtitle: Tu1752: SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) USE REDUCES RISK OF COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Creators: Abdullah Sohail
Sayed Tauseef Ahmad Jan
Adnan Malik
Muhammad M. Bhinder
Douglas G. Adler
Resource Type: Abstract
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.169(1 Suppl), p.S-1475
DOI: 10.1016/S0016-5085(25)04281-7
ISSN: 0016-5085
Language: English
Date published: 05/2025
Academic Unit: Internal Medicine
Record Identifier: 9984845451702771

1 Record Views